Some recent studies revealed that ER-α was associated with aberrant proliferation, inflammation, and the development of malignancy, whereas ER-β seemed to oppose ER-α actions on cell proliferation by modulating the expression of many ER-α-regulated genes and exhibits anti-migratory and anti-invasive properties in cancer cells [77]. The gene discussed is ESR1; the disease is cancer.